Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 22:18:37 GMT 2025
by
admin
on
Mon Mar 31 22:18:37 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG2/4 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
64EUX713G6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C20401
Created by
admin on Mon Mar 31 22:18:37 GMT 2025 , Edited by admin on Mon Mar 31 22:18:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9307
Created by
admin on Mon Mar 31 22:18:37 GMT 2025 , Edited by admin on Mon Mar 31 22:18:37 GMT 2025
|
PRIMARY | |||
|
1073059-33-2
Created by
admin on Mon Mar 31 22:18:37 GMT 2025 , Edited by admin on Mon Mar 31 22:18:37 GMT 2025
|
PRIMARY | |||
|
Samalizumab
Created by
admin on Mon Mar 31 22:18:37 GMT 2025 , Edited by admin on Mon Mar 31 22:18:37 GMT 2025
|
PRIMARY | |||
|
300000021899
Created by
admin on Mon Mar 31 22:18:37 GMT 2025 , Edited by admin on Mon Mar 31 22:18:37 GMT 2025
|
PRIMARY | |||
|
DB12636
Created by
admin on Mon Mar 31 22:18:37 GMT 2025 , Edited by admin on Mon Mar 31 22:18:37 GMT 2025
|
PRIMARY | |||
|
64EUX713G6
Created by
admin on Mon Mar 31 22:18:37 GMT 2025 , Edited by admin on Mon Mar 31 22:18:37 GMT 2025
|
PRIMARY | |||
|
CHEMBL1743067
Created by
admin on Mon Mar 31 22:18:37 GMT 2025 , Edited by admin on Mon Mar 31 22:18:37 GMT 2025
|
PRIMARY | |||
|
C77891
Created by
admin on Mon Mar 31 22:18:37 GMT 2025 , Edited by admin on Mon Mar 31 22:18:37 GMT 2025
|
PRIMARY | |||
|
WW-105
Created by
admin on Mon Mar 31 22:18:37 GMT 2025 , Edited by admin on Mon Mar 31 22:18:37 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_131 | 3_214 |
| 1_144 | 1_200 |
| 1_219 | 2_219 |
| 1_220 | 2_220 |
| 1_223 | 2_223 |
| 1_226 | 2_226 |
| 1_257 | 1_317 |
| 1_363 | 1_421 |
| 2_22 | 2_96 |
| 2_131 | 4_214 |
| 2_144 | 2_200 |
| 2_257 | 2_317 |
| 2_363 | 2_421 |
| 3_23 | 3_88 |
| 3_134 | 3_194 |
| 4_23 | 4_88 |
| 4_134 | 4_194 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_293 |
| N | 2_293 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| amino acid substitution | [1_1] [2_1] | PIDOLIC ACID | SZB83O1W42 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|